Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Sparkling Quarter But Lackluster Outlook Could Tarnish Tiffany & Co. (TIF)

Page 1 of 2

After years of being tight-fisted, consumers worldwide appear a bit more ready to splurge. Thanks to record breaking stock market rallies and rising home prices, many Americans are feeling more jubilant about the economy and their financial situation. Plus, scores of Europeans are shrugging off sovereign debt woes and spending.

Tiffany & Co. (NYSE:TIF) recently reported a 2.5% net increase in quarterly earnings. The gain was thanks to robust overseas operations, which offset lackluster results stateside, and a declining yen.

Tiffany & Co. (NYSE:TIF)

Also giving a shine to shares were promotions tied to Tiffany & Co. (NYSE:TIF)’s 175th anniversary and the film The Great Gatsby, which the company designed jewelry for.

For the quarter ended April 30, Tiffany & Co. (NYSE:TIF) posted a $83.6 million profit, or $0.63 per share, up from $81.5 million, or $0.64 cents a share a year ago. Sales rose 9.3%, to $895.5 million, and increased 13% excluding foreign currency exchange effects. Same store sales rose 4%.

The results handily beat analysts’ tempered forecasts of $0.52 per share on revenue of $855 million, and a same store sales increase of 1.5%.

The muted projections came amid Tiffany & Co. (NYSE:TIF)’s earlier warning that fiscal Q1 adjusted earnings could slip 15%-20% due to pressures on gross margins and higher marketing related costs.

Following the upbeat quarter, CFO Patrick McGuiness cautioned that present quarter and full year results might not be as sparking “especially in light of the underlying softness in the Americas” and the “further weakening of the yen.”

Japan was a notable bright spot in the latest quarter, Sales soared 20%, beating expectations and logging the best showing of any region. Any dip in sales from the Asian nation will indeed weigh on Tiffany & Co. (NYSE:TIF)’s bottom line. But with Japanese consumers encouraged to spend, any drop off may be minimal.

A new chapter in luxury goods

In April, luxury handbag maker Coach, Inc. (NYSE:COH) reported a 7% increase in overall revenue to $1.19 billion. Sales grew 7% in North America and 6% in international markets. The healthiest showing came from China, where sales soared a whopping 40%.

“We’re pleased with the progress we’re making toward our transformation to a global lifestyle brand, anchored in accessories,” said CEO Lew Frankfort.

Also pleased were investors. Shareholders bagged a 13% increase in Coach, Inc. (NYSE:COH)’s annual dividend to $1.35 a share. The stock also jumped to its highest level in some four months.

Coach has introduced a vast array of accessories for men and women in attempts to lure new, younger customers. Yet at the same time, it’s been careful not to stray too far from its classic handbags (its cash cow), which benefit from a loyal following.

In an effort to keep up with competition, Coach is expanding.

Upstarts like Michael Kors Holdings Ltd (NYSE:KORS) and Tory Burch have muscled their way into Coach’s once dominant territory. So, Coach is growing its line, aiming to become a full lifestyle brand.

An “amplified” roll-out of footwear debuted this spring, and will be followed by an increase in men’s and women’s apparel, outerwear, watches and jewelry. Stores will also get a makeover. Analysts caution Coach runs the risk of having too many or too few sizes of shoes and clothing in stock. That hasn’t been a problem with handbags and accessories. Too much in-store inventory could put the company’s legendary profitability at risk. But the change could put more than loose change in investors’ purses, handbags, and pants pockets.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!